On the Frontlines of Non-Small Cell Lung Cancer
Stay current on the latest developments in the field with On the Frontlines of Non-Small Cell Lung Cancer, an exclusive podcast series featuring expert perspectives on emerging data, evolving treatment approaches, and other key considerations.
Making the Most of Biomarker Testing in NSCLC
On the Frontlines of Non-Small Cell Lung CancerMaking the Most of Biomarker Testing in NSCLC
Steve Jackson, PharmD
Angel Qin, MD
Neoadjuvant and Adjuvant Therapy in Early-Stage NSCLC
On the Frontlines of Non-Small Cell Lung CancerNeoadjuvant and Adjuvant Therapy in Early-Stage NSCLC
Steve Jackson, PharmD
David Carbone, MD, PhD
Zidesamtinib for ROS1-Positive Non-Small Cell Lung Cancer
On the Frontlines of Non-Small Cell Lung CancerZidesamtinib for ROS1-Positive Non-Small Cell Lung Cancer
Ryan Quigley
Alexander Drilon, MD
Molecular Testing in Advanced Non-Small Cell Lung Cancer
On the Frontlines of Non-Small Cell Lung CancerMolecular Testing in Advanced Non-Small Cell Lung Cancer
Alexandria May, PharmD, BCPS
Timothy F. Burns, MD, PhD
Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care
Project Oncology®Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care
Jacob Sands, MD
Aakesh Desai, MD, MPH
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Project Oncology®NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Jacob Sands, MD
Liza Villaruz, MD
- advertisement